Physician profile
Sanjay Sood
NPI 1255451811
$441.67
in general payments reported to CMS, 2019-2025
12 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.42 · 2020: $11.06 · 2021: $146 · 2022: $12.98 · 2023: $62.95 · 2024: $28.22 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $128.10 | 2025 | Rotarexs 6 F X 135 Cm |
| Glaxosmithkline, LLC. | $114.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.48 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.46 | 2023 | Entyvio |
| Smith+Nephew, INC. | $25.42 | 2025 | Collagenase Santyl |
| Novo Nordisk INC | $19.86 | 2023 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $17.48 | 2021 | |
| Pfizer INC. | $15.63 | 2023 | |
| Abbvie INC. | $14.50 | 2024 | |
| Braintree Laboratories, INC. | $13.72 | 2024 | Sutab, Suflave |
| Amgen INC. | $13.13 | 2021 | |
| Boston Scientific Corporation | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.